Sernova Biotherapeutics Inc
SEOVF
$0.1219
$0.00141.16%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.38M | 1.56M | 1.44M | 1.56M | 1.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.04M | 3.38M | 3.43M | 5.22M | 7.22M |
| Operating Income | -3.04M | -3.38M | -3.43M | -5.22M | -7.22M |
| Income Before Tax | -2.63M | -4.00M | -3.63M | -5.50M | -7.33M |
| Income Tax Expenses | 25.90K | 4.50K | 5.10K | -- | -- |
| Earnings from Continuing Operations | -2.66M | -4.01M | -3.64M | -5.50M | -7.33M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.66M | -4.01M | -3.64M | -5.50M | -7.33M |
| EBIT | -3.04M | -3.38M | -3.43M | -5.22M | -7.22M |
| EBITDA | -3.01M | -3.34M | -3.33M | -5.13M | -7.15M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 328.48M | 327.47M | 317.49M | 303.59M | 303.40M |
| Average Diluted Shares Outstanding | 328.48M | 327.47M | 317.49M | 303.59M | 303.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |